{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T03:21:28Z","timestamp":1782789688634,"version":"3.54.5"},"reference-count":34,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100008322","name":"CSL Behring","doi-asserted-by":"publisher","award":["2012\\u2013001670-28"],"award-info":[{"award-number":["2012\\u2013001670-28"]}],"id":[{"id":"10.13039\/100008322","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of Emergency Medicine"],"published-print":{"date-parts":[[2023,2]]},"DOI":"10.1016\/j.ajem.2022.12.001","type":"journal-article","created":{"date-parts":[[2022,12,5]],"date-time":"2022-12-05T14:00:38Z","timestamp":1670248838000},"page":"121-128","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["Efficacy of human C1 esterase inhibitor concentrate for treatment of ACE-inhibitor induced angioedema"],"prefix":"10.1016","volume":"64","author":[{"given":"Ulrich","family":"Strassen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Murat","family":"Bas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Magdalena","family":"Wirth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Markus","family":"Wirth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Moritz","family":"Gr\u00f6ger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Klaus","family":"Stelter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"Volkenstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victoria","family":"Kehl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georg","family":"Kojda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas K.","family":"Hoffmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janina","family":"Hahn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susanne","family":"Trainotti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jens","family":"Greve","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ajem.2022.12.001_bb0005","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1001\/2013.jamainternmed.34","article-title":"Comparative risk for angioedema associated with the use of drugs that target the renin-angiotensin-aldosterone system","volume":"172","author":"Toh","year":"2012","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.ajem.2022.12.001_bb0010","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.1161\/HYPERTENSIONAHA.108.110270","article-title":"Angioedema incidence in US veterans initiating angiotensin-converting enzyme inhibitors","volume":"51","author":"Miller","year":"2008","journal-title":"Hypertension"},{"key":"10.1016\/j.ajem.2022.12.001_bb0015","doi-asserted-by":"crossref","first-page":"171","DOI":"10.2165\/00002018-199818030-00003","article-title":"ACE inhibitor-induced angioedema. Incidence, prevention and management","volume":"18","author":"Vleeming","year":"1998","journal-title":"Drug Saf Int J Med Toxicol Drug Exp"},{"key":"10.1016\/j.ajem.2022.12.001_bb0020","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1001\/jama.1988.03410070095035","article-title":"Clinical profile of angioedema associated with angiotensin converting-enzyme inhibition","volume":"260","author":"Slater","year":"1988","journal-title":"JAMA J Am Med Assoc"},{"key":"10.1016\/j.ajem.2022.12.001_bb0025","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.amjhyper.2003.09.014","article-title":"Omapatrilat and enalapril in patients with hypertension: the Omapatrilat cardiovascular treatment vs. Enalapril (OCTAVE) trial","volume":"17","author":"Kostis","year":"2004","journal-title":"Am J Hypertens"},{"key":"10.1016\/j.ajem.2022.12.001_bb0030","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1007\/s00106-003-1017-5","article-title":"ACE inhibitor-induced angioedema in the head and neck region. A matter of time?","volume":"52","author":"Bas","year":"2004","journal-title":"HNO"},{"key":"10.1016\/j.ajem.2022.12.001_bb0035","first-page":"A4449","article-title":"Increasing rate of angiotensin-converting enzyme inhibitor-related upper airway angio-oedema","volume":"59","author":"Holm","year":"2012","journal-title":"Dan Med J"},{"key":"10.1016\/j.ajem.2022.12.001_bb0040","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/S1081-1206(10)60594-7","article-title":"Multicenter study of patients with angiotensin-converting enzyme inhibitor-induced angioedema who present to the emergency department","volume":"100","author":"Banerji","year":"2008","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.ajem.2022.12.001_bb0045","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1007\/s11906-018-0859-x","article-title":"ACE inhibitor-induced angioedema: a review","volume":"20","author":"Kostis","year":"2018","journal-title":"Curr Hypertens Rep"},{"key":"10.1016\/j.ajem.2022.12.001_bb0050","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1016\/j.jemermed.2017.05.037","article-title":"Novel therapies for angiotensin-converting enzyme inhibitor\u2013induced angioedema: a systematic review of current evidence","volume":"53","author":"Riha","year":"2017","journal-title":"J Emerg Med"},{"key":"10.1016\/j.ajem.2022.12.001_bb0055","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/j.annemergmed.2010.03.032","article-title":"Therapeutic efficacy of icatibant in angioedema induced by angiotensin-converting enzyme inhibitors: a case series","volume":"56","author":"Bas","year":"2010","journal-title":"Ann Emerg Med"},{"key":"10.1016\/j.ajem.2022.12.001_bb0060","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1016\/j.jaci.2009.07.017","article-title":"Efficacy of human C1 esterase inhibitor concentrate compared with placebo in acute hereditary angioedema attacks","volume":"124","author":"Craig","year":"2009","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.ajem.2022.12.001_bb0065","doi-asserted-by":"crossref","first-page":"938.e1","DOI":"10.1016\/j.amjmed.2012.02.020","article-title":"Safety and efficacy of prophylactic nanofiltered C1-inhibitor in hereditary angioedema","volume":"125","author":"Zuraw","year":"2012","journal-title":"Am J Med"},{"key":"10.1016\/j.ajem.2022.12.001_bb0070","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1016\/j.jaci.2007.06.026","article-title":"Hereditary angioedema: a decade of human C1-inhibitor concentrate therapy","volume":"120","author":"Farkas","year":"2007","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.ajem.2022.12.001_bb0075","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2019.106081","article-title":"ACE inhibitor-mediated angioedema","volume":"78","author":"Montinaro","year":"2020","journal-title":"Int Immunopharmacol"},{"key":"10.1016\/j.ajem.2022.12.001_bb0080","doi-asserted-by":"crossref","first-page":"E198","DOI":"10.1002\/lary.25113","article-title":"Effect of C1-esterase-inhibitor in angiotensin-converting enzyme inhibitor-induced angioedema: C1-INH in ACE inhibitor-induced angioedema","volume":"125","author":"Greve","year":"2015","journal-title":"Laryngoscope"},{"key":"10.1016\/j.ajem.2022.12.001_bb0085","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1177\/0897190016677427","article-title":"C1 esterase inhibitor (Berinert) for ACE inhibitor-induced angioedema: two case reports","volume":"30","author":"Leibfried","year":"2017","journal-title":"J Pharm Pract"},{"key":"10.1016\/j.ajem.2022.12.001_bb0090","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1002\/ccr3.171","article-title":"Angiotensin-converting enzyme inhibitors-induced angioedema treated by C1 esterase inhibitor concentrate (Berinert\u00ae): about one case and review of the therapeutic arsenal","volume":"3","author":"Lipski","year":"2015","journal-title":"Clin Case Rep"},{"key":"10.1016\/j.ajem.2022.12.001_bb0095","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.1016\/S0140-6736(97)09137-X","article-title":"Plasma bradykinin in angio-oedema","volume":"351","author":"Nussberger","year":"1998","journal-title":"Lancet"},{"key":"10.1016\/j.ajem.2022.12.001_bb0100","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1111\/j.1398-9995.2011.02686.x","article-title":"New topics in bradykinin research","volume":"66","author":"Maurer","year":"2011","journal-title":"Allergy"},{"key":"10.1016\/j.ajem.2022.12.001_bb0105","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.1016\/j.jaci.2018.06.037","article-title":"Endogenous bradykinin and BK1-5 during ACE inhibitor-associated angioedema","volume":"142","author":"Hubers","year":"2018","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.ajem.2022.12.001_bb0110","doi-asserted-by":"crossref","first-page":"358","DOI":"10.3389\/fmed.2020.00358","article-title":"Measurement of bradykinin formation and degradation in blood plasma: relevance for acquired angioedema associated with angiotensin converting enzyme inhibition and for hereditary angioedema due to factor XII or plasminogen gene variants","volume":"7","author":"Marceau","year":"2020","journal-title":"Front Med"},{"key":"10.1016\/j.ajem.2022.12.001_bb0115","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1177\/0194599817737974","article-title":"Pharmacotherapy for angiotensin-converting enzyme inhibitor\u2013induced angioedema: a systematic review","volume":"158","author":"Lawlor","year":"2018","journal-title":"Otolaryngol Neck Surg"},{"key":"10.1016\/j.ajem.2022.12.001_bb0120","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1111\/jch.13097","article-title":"Angiotensin-converting enzyme inhibitor-induced angioedema: a review of the literature","volume":"19","author":"Brown","year":"2017","journal-title":"J Clin Hypertens Greenwich Conn"},{"key":"10.1016\/j.ajem.2022.12.001_bb0125","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1111\/jcpt.12997","article-title":"Effect of icatibant on angiotensin-converting enzyme inhibitor-induced angioedema: a meta-analysis of randomized controlled trials","volume":"44","author":"Jeon","year":"2019","journal-title":"J Clin Pharm Ther"},{"key":"10.1016\/j.ajem.2022.12.001_bb0130","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1056\/NEJMoa1312524","article-title":"A randomized trial of Icatibant in ACE-inhibitor\u2013induced angioedema","volume":"372","author":"Ba\u015f","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ajem.2022.12.001_bb0135","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1016\/j.jaip.2017.03.003","article-title":"Randomized trial of icatibant for angiotensin-converting enzyme inhibitor\u2013induced upper airway angioedema","volume":"5","author":"Sinert","year":"2017","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.ajem.2022.12.001_bb0140","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.jaci.2016.09.051","article-title":"Effect of bradykinin receptor antagonism on ACE inhibitor-associated angioedema","volume":"140","author":"Straka","year":"2017","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.ajem.2022.12.001_bb0145","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1016\/j.otohns.2007.08.012","article-title":"Clinical experience with angiotensin-converting enzyme inhibitor\u2013induced angioedema","volume":"137","author":"Grant","year":"2007","journal-title":"Otolaryngol Head Neck Surg"},{"key":"10.1016\/j.ajem.2022.12.001_bb0150","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1016\/j.amjcard.2011.11.014","article-title":"Angiotensin-converting enzyme (ACE) inhibitor angioedema: the silent epidemic","volume":"109","author":"Roberts","year":"2012","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.ajem.2022.12.001_bb0155","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.anai.2013.06.021","article-title":"Effect of time to treatment on response to C1 esterase inhibitor concentrate for hereditary angioedema attacks","volume":"111","author":"Craig","year":"2013","journal-title":"Ann Allergy Asthma Immunol Off Publ Am Coll Allergy Asthma Immunol"},{"key":"10.1016\/j.ajem.2022.12.001_bb0160","first-page":"L645","article-title":"Stimulation of bovine pulmonary artery endothelial cell ACE by dexamethasone: involvement of steroid receptors","volume":"263","author":"Dasarathy","year":"1992","journal-title":"Am J Physiol"},{"key":"10.1016\/j.ajem.2022.12.001_bb0165","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1007\/s00063-018-0483-1","article-title":"Ulmer Notfallalgorithmus: die Akuttherapie von medikamenteninduzierten bradykininvermittelten Angio\u00f6demen","volume":"114","author":"Hahn","year":"2019","journal-title":"Med Klin Intensivmed Notfallmedizin"},{"key":"10.1016\/j.ajem.2022.12.001_bb0170","article-title":"Genetic susceptibility to angiotensin-converting enzyme-inhibitor induced angioedema: a systematic review and evaluation of methodological approaches","volume":"14","author":"Ali","year":"2019","journal-title":"PLoS One"}],"container-title":["The American Journal of Emergency Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0735675722007434?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0735675722007434?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T18:18:50Z","timestamp":1777573130000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0735675722007434"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2]]},"references-count":34,"alternative-id":["S0735675722007434"],"URL":"https:\/\/doi.org\/10.1016\/j.ajem.2022.12.001","relation":{},"ISSN":["0735-6757"],"issn-type":[{"value":"0735-6757","type":"print"}],"subject":[],"published":{"date-parts":[[2023,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Efficacy of human C1 esterase inhibitor concentrate for treatment of ACE-inhibitor induced angioedema","name":"articletitle","label":"Article Title"},{"value":"The American Journal of Emergency Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajem.2022.12.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}